ArticleInternational journal of clinical and experimental pathology2017
Clinical significance of Vδ1 T cell detection in sepsis patients.
Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study is to investigate changes of the number of PB Vδ1 T cells and their function in patients with sepsis, analyze the clinical significance of Vδ1 T cell detection and validate the effects of Vδ1 T cells on the onset of sepsis. Forty patients with sepsis were included into this study together with forty healthy subjects who received the physical examination in the hospital during the same period, and the clinical data of all subgroups of patients with sepsis were recorded. In the morning, the fasting peripheral venous blood at 10 ml was sampled from patients with sepsis and subjects in the Health Control (HC) group. The flow cytometry (FCM) was used to measure the percentage of Vδ1 T cells in PB, analyze the correlation between the percentage of Vδ1 T cells, APACHEII score and blood lactic acid level in patients with sepsis, and detect the expression level of Foxp3 on the surface of Vδ1 T cells. CFSE staining method was used to detect the influence of Vδ1 T cells on the proliferation capacity of naïve CD4 T cells. Compared with the HC group, the number of Vδ1 T cells in PB was significantly increased in patients with sepsis (P<0.01), and the sepsis shock group exhibited the highest expression level of Vδ1 T cells, followed by the severe sepsis group and the sepsis group. The percentage of Vδ1 T cells in patients with sepsis was positively correlated with APACHEII score and the lactic acid level, respectively. Compared with the HC group, the expression level of Foxp3 on the surface of Vδ1 T cells in PB was significantly increased in patients with sepsis (P<0.01), with the highest expression level of Foxp3 in the sepsis shock group, followed by the severe sepsis group and the sepsis group. In the HC group and patients with sepsis, the proliferation rate of naïve CD4 T cells co-incubated by Vδ1 T cells and naïve CD4 T cells in PB was (66.94±8.91)% and (47.24±9.86)%, respectively. Vδ1 T cells in PB of patients with sepsis exhibited obviously increased inhibition on the proliferation of naïve CD4 T cells, indicating that PB Vδ1 T cells in patients with sepsis presented stronger immunosuppressive functions than those in the HC group (P<0.01). The percentage of PB Vδ1 T cells in patients with sepsis was increased and the immunosuppressive function was increased, so that immune function of patients with sepsis was inhibited and then sepsis occurred. This indicated that Vδ1 T cells in PB might play important roles in the immune pathogenesis of sepsis and provide clinical values in the evaluation of prognosis.
Indexed as
Identifiers
31966586PMC6965301W3011813386What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.